Tonghua Dongbao Pharmaceutical Co Ltd Cash Flow Quality Index
Tonghua Dongbao Pharmaceutical Co Ltd cash flow quality index. Tonghua Dongbao Pharmaceutical Co Ltd (600867) has a Cash Flow Quality Index of 0.06x as of September 2025. Operating cash flow of CN¥62.99 Million is below net income of CN¥984.48 Million, suggesting accrual-heavy earnings not yet converted to cash. See Tonghua Dongbao Pharmaceutical Co Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Tonghua Dongbao Pharmaceutical Co Ltd (1998–2025)
Cash flow quality index of Tonghua Dongbao Pharmaceutical Co Ltd from 1998 to 2025. Historical Cash Flow Quality Index for Tonghua Dongbao Pharmaceutical Co Ltd across 26 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore cash flow to debt ratio of Tonghua Dongbao Pharmaceutical Co Ltd to assess how comfortably operating cash covers total debt obligations.
Tonghua Dongbao Pharmaceutical Co Ltd Cash Flow Quality Index by Year (1998–2025)
Tonghua Dongbao Pharmaceutical Co Ltd cash flow quality index by year from 1998 to 2025. Year-by-year earnings quality comparison for Tonghua Dongbao Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Tonghua Dongbao Pharmaceutical Co Ltd operating cash flow efficiency.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.57x | CN¥689.23 Million | CN¥1.22 Billion | ▼ -23.4% |
| 2023 | 0.74x | CN¥861.52 Million | CN¥1.17 Billion | ▲ +35.2% |
| 2022 | 0.55x | CN¥863.09 Million | CN¥1.58 Billion | ▼ -37.1% |
| 2021 | 0.87x | CN¥1.13 Billion | CN¥1.31 Billion | ▼ -32.3% |
| 2020 | 1.28x | CN¥1.19 Billion | CN¥930.32 Million | ▼ -9.9% |
| 2019 | 1.42x | CN¥1.15 Billion | CN¥809.64 Million | ▲ +36.1% |
| 2018 | 1.05x | CN¥876.94 Million | CN¥838.92 Million | ▼ -8.6% |
| 2017 | 1.14x | CN¥961.19 Million | CN¥840.10 Million | ▲ +0.8% |
| 2016 | 1.14x | CN¥725.76 Million | CN¥639.21 Million | ▲ +88.9% |
| 2015 | 0.60x | CN¥294.58 Million | CN¥490.06 Million | ▼ -19.3% |
| 2014 | 0.74x | CN¥205.89 Million | CN¥276.54 Million | ▼ -39.6% |
| 2013 | 1.23x | CN¥221.06 Million | CN¥179.46 Million | ▼ -62.2% |
| 2012 | 3.26x | CN¥194.32 Million | CN¥59.65 Million | ▲ +2247.2% |
| 2011 | -0.15x | CN¥-55.07 Million | CN¥362.98 Million | ▼ -116.4% |
| 2010 | 0.93x | CN¥160.40 Million | CN¥173.36 Million | ▼ -62.3% |
| 2009 | 2.46x | CN¥166.20 Million | CN¥67.68 Million | ▲ +18.5% |
| 2008 | 2.07x | CN¥92.31 Million | CN¥44.56 Million | ▲ +29.6% |
| 2007 | 1.60x | CN¥120.94 Million | CN¥75.69 Million | ▼ -86.6% |
| 2006 | 11.90x | CN¥158.00 Million | CN¥13.27 Million | ▲ +132.2% |
| 2005 | 5.13x | CN¥92.23 Million | CN¥17.99 Million | ▲ +330.2% |
| 2003 | 1.19x | CN¥45.51 Million | CN¥38.18 Million | ▲ +65.3% |
| 2002 | 0.72x | CN¥31.99 Million | CN¥44.38 Million | ▼ -81.0% |
| 2001 | 3.79x | CN¥117.73 Million | CN¥31.04 Million | ▲ +525.4% |
| 2000 | 0.61x | CN¥29.12 Million | CN¥48.02 Million | ▲ +145.6% |
| 1999 | -1.33x | CN¥-95.09 Million | CN¥71.55 Million | ▲ +44.5% |
| 1998 | -2.39x | CN¥-216.98 Million | CN¥90.66 Million | — |